Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
Debating Point
MA shows up government's double game on rebates
Medicines Australia's 2017 budget submission has called time on the government's trick of ignoring the inconvenient reality that most new PBS spending is capped.
Approvals Action
Bayer registers five year contraceptive
Bayer has won TGA approval for an intrauterine contraceptive indicated for contraception up to five years while Aspen Pharma's status as the only PBS supplier of ADHD treatment dexamphetamine looks like it's under threat.
Pipeline Monitor
MSD makes first Keytruda combo filing
European approval for Sanofi's new diabetes combo while MSD and Roche look for new cancer blockbuster indications in the US.